Abnehmmittel: Abnehmspritze könnte offenbar bald Kassenleistung werden
Laut dem scheidenden Barmer-Chef könnte die Abnehmspritze künftig von den gesetzlichen Krankenkassen bezahlt werden. Steigende Kosten für Krankenkassen sollen dabei nicht entstehen.
Düsseldorf - The Barmer's outgoing chief, Christoph Straub, anticipates that the obesity injection could soon be covered by statutory health insurers. "I assume that we will also include the obesity injection as a therapy option," Straub told the NPG Redaktion's partner publications. Straub believes the costs for the health insurers should not surge dramatically, provided drug prices are more aligned with actual benefits. "To manage cost implications, and must be reduced during negotiations," he emphasized.
Straub noted that patients with pathological obesity should not have to prove they have already unsuccessfully tried diets or increased physical activity before undergoing such therapy. Operative procedures for treating obesity have already waived such a prerequisite. "The same should apply to the injection therapy," Straub concluded.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.